Conference abstract · 25 Aug 2020
Conference abstractPublished 12 Sep 2011
From bench to bedside
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A major goal of cancer research is to test cancer tissue at the molecular level and make therapeutic predictions. Personalized medicine is a rapidly advancing aspect of health care that is based on each person?s unique clinical, genetic, genomic and environmental information. It depends on providing a comprehensive understanding of personalized medicine from scientifi c discovery at the laboratory bench to the implementation of these novel pathways of understanding human biology at the bedside. One of the most widely used molecular profi ling services with the most accepted methods is Caris Target Now. Th e goal of Target Now is to identify clinically relevant and patient specifi c biomarkers from the patients? tumor and help inform more eff ective and targeted treatment options. A variety of tests are performed on each tumor sample including immunohistochemistry, fl uorescent in situ hybridization, microarray analysis and DNA sequencing. Th e profi led biomarkers are then reported out with drug associations. In a pilot study, treatment recommended by Target Now molecular profi ling has been shown to increase progression free survival among some patients. Caris Target Now combines comprehensive molecular pathology and tumor profi ling with an exhaustive evidence- based review of the latest clinical literature on biomarkers and their correlation to potential drug response. Th is provides treating physicians with the information needed to personalize cancer treatment. Some of the Target Now tests performed on common tumor types and their association with therapy will be discussed in detail
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 28 Feb 2025
Molecular Genetics in Precision Medicine: From Bench to Bedside
Commentary · 25 Feb 2025
Emerging Frontiers in Tumor Suppressor Research: From Bench to Bedside
Opinion · 31 Jan 2025
Genetic Variations and Personalized Medicine: From Bench to Bedside
Perspective · 29 Aug 2024
From Bench to Bedside: Translating Oncogenomics Research into Clinical Practice
More from this journal
The newest in Journal of Molecular Biomarkers & Diagnosis.
Brief report · 29 Dec 2025
Biomarker Discovery To Clinical Translation: A Holistic Approach
Commentary · 29 Dec 2025
Molecular Diagnostics: Revolutionizing Precision Healthcare
Commentary · 29 Dec 2025
Genomic Biomarkers Revolutionizing Disease Diagnosis and Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Biomarkers & Diagnosis
- SubjectGenetics & Molecular Biology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Gargi D Basu”

